BIOINVEST 2014 concludes successfully boosting investor confidence

Read more

Glenmark’s consolidated revenue increases by 15.92 per cent in Q3 FY 13-14

Read more

Biocon achieves 16 per cent growth in Q3 2013-14

Read more

SPARC gets DCGI nod for breast cancer injection paclitaxel

Read more

US FDA bans drug manufactured from Ranbaxy’s Toansa facility

Read more

Wipro cited as leader in global research and advisory firm report

Read more

Unichem Laboratories obtains ANDA approval from US FDA for metronidazole tablets

Read more

Aurobindo Pharma gets US FDA approval for repaglinide tabs

Read more

Jubilant Life Sciences revamps official website

Read more

Biocon inks pact with Advaxis for development of novel cervical cancer immunotherapy

Read more